Thu, Nov 09, 2017, 02:30 PM - Thu, Nov 09, 2017, 11:30 PM
http://www.virtueinsight.com/pharma/14th-Pharmacovigilance-2017/
14th Pharmacovigilance 2017
“Ensuring
safer drugs to market by analyzing latest developments in pharmacovigilance,
drug safety and risk management”
9th
November 2017, Kohinoor Continental Hotel, Mumbai, India
The
Pharmacovigilance conference, organized yearly by Virtue Insight, is a unique
event where key stakeholders gather with the aim of promoting patient safety
and undertaking to continue work towards a more efficient pharmacovigilance
system. This is the opportunity to engage and sit alongside the pioneers who
are driving forward innovation in pharmacovigilance.
KEY SPEAKERS:
·
S SADHWANI, Drug controller of Maharashtra and Jt.Commissioner Drug, FDA
·
K. BANGARURAJAN, Deputy Drugs
Controller, DDC(I), CDSCO
·
MUZAFFAR AHMAD, Member, Strategic Advisory Board on Health Millenium Alliance
(Govt of India) and Member Council of India
·
DAARA B. PATEL, Secretary General, Indian
Drug Manufacturers' Association
·
DEEPA ARORA, Vice President - Pharmacovigilance & Global Head - Drug Safety &
Risk Management, Lupin
·
JEAN-CHRISTOPHE DELUMEAU, Head of Pharmacovigilance Asia-Pacific, Bayer HealthCare (Singapore)
·
MANISH VERMA, Director and Head of Medical Affairs, South Asia Zone, Sanofi
·
SARABJEET KAUR, Associate Vice President- Pharmacovigilance, APCER Life Sciences
·
AMBRISH SRIVASTAVA, Vice President: Medial Affairs,Clinical Research &
Regulatory, Alkem Laboratories
·
VIKRAM GOTA, Associate Professor, ACTREC, Tata
Memorial Centre
·
BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila
·
AVINASH R.
KAKADE, Senior Director and Head of Pharmacovigilance, Cipla
·
SHUBHADEEP SINHA, Vice-President & Head (Global) - Clinical Development, Medical
Affairs & Pharmacovigilance, Hetero Labs
·
RAHUL GUPTA, Vice President, Regulatory Affairs, USV
·
SUJAY SURESH
KULKARNI, Senior Manager, Medical and Regulatory Affairs, GSK
·
MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates
·
ABHAY PHANSALKAR, Head Clinical Trials, Cipla
·
DEEPTI
SANGHAVI, Assistant Manager-Medical Writing, Tata
Consultancy Services
·
RUCHIKA SINGHAL, Business Unit Head, AstraZeneca
·
GURPREET SINGH, Head of Vendor Management in PV, Novartis
·
NIDHI VAISH DAS, Drug Safety, Roche
Pharmaceuticals
·
MANOJ SWAMINATHAN, Chief Manager / Head - Global Pharmacovigilance, Piramal
·
SHASHIDHAR SWAMY, Project Manager, Tata
Consultancy Services
·
PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research
·
RAJANI ROKADE, Founder-Director, PharmaSoulz
·
PRASHANT BODHE, Director, CliniSearch
Plus many more,,
WHO SHOULD ATTEND:
Vice
Presidents, Directors, CRO’s, Heads and Managers of:
Pharmacovigilance
Strategy, Drug Safety/Risk Management, Information and Clinical Data
Management, Clinical Research, Research & Development, Product
Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data
Analysis, Epidemiology project management, Regulatory Affairs and Compliance,
Sales & Marketing, Biotech manufacturers
Pharmaceutical
organizations, Generic pharmaceutical companies, Contract research
organizations, Patient recruitment companies, Government- Department of health,
Non-profit organizations/ Association, Consultants
CONFERENCE BOOKING
DETAILS:-
Email – kavitha@virtueinsight.co.in or TEL: + 91
9940791115
·
Conference Sponsor & Exhibition Stalls are also available. We also have sponsorship
opportunities available for the event which gives you an opportunity to
speak/exhibit and create brand awareness. In addition, the networking
opportunities in focused and relevant industry gathering provide the personal
contact necessary for business development efforts.
REGISTRATION
PROCESS:-
In order to
register simply fill in the last page of the attached file and email us back to
me or you can simply email me your invoice details in the below mentioned
format;
·
Company Name & Address:
·
GST number (if applicable):
·
Attendee Name:
·
Job Title:
·
Contact Number:
Be a
part of this conference and explore benefit-risk management strategies and
patient-centric approaches and how you can tackle the challenges of social
media and drug safety legislation globally.
Tue 06-Mar-2018
Fri 11-May-2018
Fri 27-Dec-2019
Thu 16-Mar-2023